Bardet-Biedl Syndrome 5 (BBS5) (N-Term) Peptide
BBS5
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits BBS5
- BBS5 (Bardet-Biedl Syndrome 5 (BBS5))
- Protein Region
- N-Term
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Séquence
- MSVLDALWED RDVRFDLSAQ QMKTRPGEVL IDCLDSIEDT KGNNGDRGRL
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-BBS5 Antibody(ARP52930_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- BBS5 (Bardet-Biedl Syndrome 5 (BBS5))
- Synonymes
- zgc:56578 Peptide, 1700049I01Rik Peptide, 2700023J09Rik Peptide, Bardet-Biedl syndrome 5 Peptide, Bardet-Biedl syndrome 5 (human) Peptide, bbs5 Peptide, BBS5 Peptide, Bbs5 Peptide
- Sujet
-
BBS5 is a protein that has been directly linked to Bardet-Biedl syndrome. The primary features of this syndrome include retinal dystrophy, obesity, polydactyly, renal abnormalities and learning disabilities. Experimentation in non-human eukaryotes suggests that this gene is expressed in ciliated cells and that it is required for the formation of cilia.
Alias Symbols: -
Protein Size: 341 - Poids moléculaire
- 39 kDa
- ID gène
- 129880
- NCBI Accession
- NM_152384, NP_689597
- UniProt
- Q8N3I7
-
Vous êtes ici:
